Jae-Min Yuk Selected Research

Sepsis (Septicemia)

4/2017	Inositol polyphosphate multikinase promotes Toll-like receptor-induced inflammation by stabilizing TRAF6.
1/2013	Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2.
7/2011	The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors.
3/2009	A dual regulatory role of apurinic/apyrimidinic endonuclease 1/redox factor-1 in HMGB1-induced inflammatory responses.
9/2008	The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Min Yuk Research Topics

Disease

21	Infections 12/2021 - 01/2009
8	Inflammation (Inflammations) 07/2020 - 10/2009
6	Toxoplasmosis 10/2021 - 01/2016
5	Sepsis (Septicemia) 04/2017 - 09/2008
5	Tuberculosis (Tuberculoses) 07/2014 - 04/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 01/2016
3	Septic Shock (Toxic Shock Syndrome) 12/2016 - 09/2008
2	Neoplasms (Cancer) 07/2020 - 01/2010
2	Communicable Diseases (Infectious Diseases) 09/2019 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 07/2012 - 03/2009
2	Shock 10/2009 - 09/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Ocular Toxoplasmosis 01/2020
1	Ulcerative Colitis 01/2019
1	Colitis 01/2019
1	Parasitic Diseases (Parasitic Disease) 11/2018
1	Ischemia 01/2016
1	Ischemic Stroke 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014
1	Colonic Neoplasms (Colon Cancer) 01/2010
1	Hypoxia (Hypoxemia) 11/2009
1	Bacterial Infections (Bacterial Infection) 04/2009

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2018 - 08/2008
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2014
4	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2017 - 08/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2009
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2013
3	InflammasomesIBA 07/2020 - 07/2012
3	EndotoxinsIBA 07/2015 - 09/2008
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2009
2	4-phenylbutylamineIBA 12/2021 - 01/2021
2	SilverIBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2015
2	ResveratrolIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 12/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 12/2010
2	VaccinesIBA 01/2016 - 07/2014
2	AntigensIBA 01/2016 - 07/2014
2	p38 Mitogen-Activated Protein KinasesIBA 08/2015 - 08/2008
2	LigandsIBA 10/2009 - 09/2008
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2009 - 09/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009 - 04/2009
1	Cysteine (L-Cysteine)FDA Link 12/2021
1	4-phenylbutyric acid (Buphenyl)FDA Link 12/2021
1	MAP Kinase Kinase Kinase 5IBA 12/2021
1	pyrazolanthroneIBA 12/2021
1	Matrix Metalloproteinases (MMPs)IBA 12/2021
1	Retinal Pigments (Pigments, Visual)IBA 10/2021
1	Biological ProductsIBA 07/2020
1	4- (1- (4- hydroxyphenyl)- 2- phenylbuten- 1- yl)phenoxy- n- butyric acidIBA 02/2020
1	Antiparasitic Agents (Antiparasitics)IBA 02/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	AMP-Activated Protein KinasesIBA 11/2018
1	Antiviral Agents (Antivirals)IBA 11/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	polyphosphate kinaseIBA 04/2017
1	LipopolysaccharidesIBA 04/2017
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 04/2017
1	inositol polyphosphate multikinaseIBA 04/2017
1	Inositol (Myoinositol)IBA 04/2017
1	NADPH Oxidase 4IBA 01/2017
1	Macrophage Migration-Inhibitory FactorsIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Neuroprotective AgentsIBA 01/2016
1	ChemokinesIBA 12/2015
1	Orphan Nuclear ReceptorsIBA 07/2015
1	Estrogens (Estrogen)FDA Link 07/2015
1	Interleukin-23 (Interleukin 23)IBA 01/2015
1	Interleukin-12 (IL 12)IBA 01/2015
1	Uncoupling Protein 2IBA 01/2013
1	Fenofibrate (CiL)FDA LinkGeneric 01/2013
1	Isoniazid (Ftivazide)FDA LinkGeneric 05/2012
1	Pyrazinamide FDA LinkGeneric 05/2012
1	Vitamin D FDA LinkGeneric 10/2011
1	CathelicidinsIBA 01/2011
1	Radiation-Sensitizing AgentsIBA 01/2010
1	CaspasesIBA 01/2010
1	Beclin-1IBA 01/2010
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 01/2010
1	3-methyladenineIBA 01/2010
1	NF-kappa B (NF-kB)IBA 11/2009
1	protopanaxadiolIBA 10/2009
1	ZymosanIBA 10/2009
1	dectin 1IBA 10/2009
1	ginsenoside M1IBA 10/2009
1	Interferon-gamma (Interferon, gamma)IBA 10/2009
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2009
1	VitaminsIBA 09/2009
1	NitrogenIBA 04/2009
1	Pattern Recognition ReceptorsIBA 04/2009
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2009
1	HMGB1 Protein (HMG1)IBA 03/2009
1	20- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA 09/2008

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2008
1	Intravenous Administration 12/2016
1	Radiotherapy 01/2010